Drug intelligence / Profile preview

full-length human dystrophin

Development stage
Unknown
Modality
Gene Therapies, Recombinant Proteins and Enzymes
Administration
Intramuscular
01

Overview

Full-length human dystrophin is a large sarcolemmal protein crucial for maintaining muscle membrane integrity. Mutations in the dystrophin gene cause Duchenne muscular dystrophy (DMD), an X-linked recessive disorder characterized by progressive muscle degeneration. Due to its substantial size (2.4 Mb gene, >11 kb cDNA, 427 kDa protein), delivering the full-length dystrophin gene for therapeutic purposes presents significant challenges for gene therapy. Various approaches, including human artificial chromosomes (HACs), piggyBac transposons, and adeno-associated viral (AAV) vectors, are being explored to enable its expression in muscle cells to ameliorate DMD phenotypes.

02

Targets

DTN (Dystrobrevin)F-actin (Filamentous actin)NOS1 (nNOS)SNT (Syntrophin)DAG1 (Dystroglycan 1)DMD (Dystrophin)

Beyond the preview

Go deeper on full-length human dystrophin.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on full-length human dystrophin.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call